Explore the full directors' dealings record of Ambrx Biopharma, Inc., a listed equity based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Market capitalisation: €1.8bn. The latest transaction was filed on 7 March 2024 (Disposition). Among the most active insiders: Nelson Sonja. Every trade is free.
8
Insider Decl.
0
Thresholds
€9m
1 ops.
Buy Volume
€583,653
4 ops.
Sell Volume
42Σ signal
Buys €9m€583,653 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.